After the joy of watching the Interactive update s
Post# of 148288
Quote:
But we have 9 patients in our basket trial, prostate cancer, you know, other cancers that they are in the 22 different solid tumor cancer that they can get enrolled … they are going on almost a year now and the markings of CTC, circulating tumor cells, is almost zero in all of them. That is unheard of, we are meeting with FDA, we have asked for pre-breakthrough designation, I believe the process of asking is on their way, as soon as we get in front of the FDA we will show these results, the anecdotal, and the trial that we have, and we will ask guidance: what do we do, and we have a product that if we believe the patients, of the words they are using it, are just blown away, some of them, and are giving testimony, it does not work that way for everybody but it has worked for a lot of people.
We are exited to go forward with that.
Well .... I don't know about you but, if even one tenth of what NP is saying is a fact, we should be jumping up and down.
And the SP should be jumping UP.
Luckily it hasn't (and probably won't) because there is no efficiency in the markets (share price reflect all information), which is fine and allows me to profit, as the crowd will react as they always do: when it is too late.
In one thing he is 100% correct: this is unheard of.
Now, let's get back to earth (CC + zero CTC counts in the same Proactive is probably too much to handle for me). A sizable reduction of CTC's FOR A YEAR FOR SEVERAL PATIENTS is in the realm of several digits ...
Trying not to exaggerate here. And this is ground
The question is: are we really getting such results ??.
Pufffff ... I think I better go back and watch again ....